Doctor Martin Unverdorben
Daiichi Sankyo, Inc., Basking Ridge, NJ (United States of America)
One-year effectiveness and safety outcomes of edoxaban treatment in Chinese patients with atrial fibrillation: First snapshot of more than 4,800 patients from the ETNA-AF-China study
Event: EHRA 2024
Topic: Stroke in Atrial Fibrillation
Session: Poster session on devices, others
Periprocedural management of patients on edoxaban undergoing pacemaker and cardiac monitoring device implantation - a sub-analysis of the EMIT-AF/VTE study
Event: EHRA 2021
Topic: Oral Anticoagulation
Session: ePoster session
